Sunday, December 13, 2020

MassMutual’s LifeScore Labs and Antara Health Partner to Explore Risk Scoring in Healthcare

 Risk scoring will measure impact, improve patient experience, and achieve better health outcomes by generating data needed to create affordable life and health products for the middle class

BOSTON-Friday 11 December 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- LifeScore Labs™, a subsidiary of Massachusetts Mutual Life Insurance Company (MassMutual), and healthcare startup Antara Health today announced a collaboration to explore how risk scoring can impact health outcomes in emerging markets.

Antara Health, which uses virtual health navigation and AI to scale patient-centered healthcare, will use the easy-to-understand results of LifeScore Labs’ standards-based algorithmic risk scoring solution, LifeScore Med360℠, to explore opportunities to better scale its service. The startup will also use the tool to gain new insights into members’ long-term risk profiles.

Antara provides turnkey virtual health services for insurance plans. Its integrated approach combines screening and early detection, customized health engagement plans, and high-touch virtual engagement. This catalyzes effective behavior modification that can achieve better health outcomes for middle class consumers at significantly lower costs.

“We are thrilled to work with an innovative startup like Antara Health to explore the benefits of using mortality risk scores in emerging market healthcare systems,” said Michael Gallary, COO & Head of LifeScore Labs. “We believe that this technology, originally developed for the life insurance industry, will provide Antara with efficient, clear risk assessments, while helping people live longer, healthier lives.”

LifeScore Med360℠ is an advanced medical-based risk assessment algorithm, distinct to the industry, leveraging millions of data points over decades of experience to produce a comprehensive mortality risk score. It is a secure, web-based solution that utilizes de-identified data inputs to provide a risk score, detailed visualization of contributing factors and a median risk comparison to other individuals within a cohort.

“We are excited to partner with the team at LifeScore Labs because they provide a high quality comprehensive algorithmic mortality score. Continuous risk assessment can help us deliver more effective care to our members by helping us better measure the impact of the care we provide,” said Dr. Kebba Jobarteh, Antara’s Co-Founder and CEO. “We think the data generated from this collaboration can help unlock new insurance products that will be very attractive in our market.”

Together, MassMutual’s LifeScore Labs and Antara Health will use LifeScore Med360℠ to deliver new insight into comprehensive mortality risk scores in emerging markets, hoping to create more affordable life and health products within those markets through its experimental collaboration. The downstream potential of this collaboration will be to innovate those insights into newly affordable and attractive health and life products class around the world.

About LifeScore Labs, LLC

LifeScore Labs, LLC (LifeScore Labs), a wholly owned subsidiary of MassMutual, was established in 2017 to bring to market selected intellectual property created by MassMutual's Data Science team. LifeScore Labs delivers a toolkit of data-driven risk-scoring models that make underwriting more efficient while generating results that are easier to interpret for both insurers and consumers. For more information on LifeScore Labs, visit

About Antara Health

Antara Health scales patient-centered health care for everyone by adding AI-assisted health navigation to make the hard parts of healthcare easy for patients and providers. Patients, especially those with chronic ailments, enjoy comprehensive health and financial protection, concierge care coordination, and peace of mind knowing they and their loved ones have a champion in their healthcare journey. For more information, visit


View source version on


LifeScore Labs

Chelsea Haraty

(413) 744 4062

Permalink :

No comments:

Post a Comment